Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial
-
Published:2024-09-02
Issue:
Volume:
Page:
-
ISSN:1078-8956
-
Container-title:Nature Medicine
-
language:en
-
Short-container-title:Nat Med
Author:
Adedinsewo Demilade A.ORCID, Morales-Lara Andrea Carolina, Afolabi Bosede B.ORCID, Kushimo Oyewole A.ORCID, Mbakwem Amam C., Ibiyemi Kehinde F.ORCID, Ogunmodede James Ayodele, Raji Hadijat OlaideORCID, Ringim Sadiq H.ORCID, Habib Abdullahi A., Hamza Sabiu M.ORCID, Ogah Okechukwu S., Obajimi Gbolahan, Saanu Olugbenga Oluseun, Jagun Olusoji E., Inofomoh Francisca O.ORCID, Adeolu Temitope, Karaye Kamilu M.ORCID, Gaya Sule A., Alfa Isiaka, Yohanna Cynthia, Venkatachalam K. L., Dugan Jennifer, Yao XiaoxiORCID, Sledge Hanna J., Johnson Patrick W., Wieczorek Mikolaj A., Attia Zachi I.ORCID, Phillips Sabrina D., Yamani Mohamad H., Tobah Yvonne ButlerORCID, Rose Carl H., Sharpe Emily E.ORCID, Lopez-Jimenez Francisco, Friedman Paul A.ORCID, Noseworthy Peter A.ORCID, Carter Rickey E.,
Funder
Mayo Clinic | Center for Clinical and Translational Science, Mayo Clinic
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Goli, R. et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation 143, 1852–1862 (2021). 2. Gunderson, E. P. et al. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet. Gynecol. 118, 583–591 (2011). 3. Karaye, K. M. et al. Clinical features and outcomes of peripartum cardiomyopathy in nigeria. J. Am. Coll. Cardiol. 76, 2352–2364 (2020). 4. Karaye, K. M. et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry. ESC Heart Fail. 7, 235–243 (2020). 5. Isogai, T. & Kamiya, C. A. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality. Int. Heart J. 60, 503–511 (2019).
|
|